Cite
HARVARD Citation
Tillett, W. et al. (n.d.). OA36 Bimekizumab in patients with psoriatic arthritis: achievement and maintenance of Psoriatic Arthritis Response Criteria responses through 3 years in a phase 2b open-label extension study. Rheumatology. p. . [Online].